Icahn Carl C10% Owner
Sell $542.4M of disclosed value in Xerox Holdings Corp $XRX.
Sell
Market Actions for September 2023
Moskovitz Dustin A.Director, President, CEO, , Chair, 10% Owner
Buy $11.7M of disclosed value in Asana, Inc. $ASAN.
Buy
Bardin Hill Investment Partners LPInstitutional Owner
Sell $2.4M of disclosed value in NextDecade Corporation $NEXT.
Sell
Whitehead Dane EExecutive VP, CFO
Sell $1.4M of disclosed value in Marathon Oil Corporation $MRO.
Sell
Repertoire Master Fund LP10% Owner
Sell $1.8M of disclosed value in BCP Investment Corporation $BCIC.
Sell
Henderson Michael AExecutive VP, Operations
Sell $1.0M of disclosed value in Marathon Oil Corporation $MRO.
Sell
Chiang Willie CWDirector, Chair, CEO
Buy $1.0M of disclosed value in Plains GP Holdings, L.P. $PAGP.
Buy
EdisonFuture, Inc.10% Owner
Sell $12.2M of disclosed value in Phoenix Motor Inc. $PEV.
Sell
Saba Capital Management, L.P.10% Owner
Sell $8.8M of disclosed value in Iris Acquisition Corp $IRAAW.
Sell
Saba Capital Management, L.P.10% Owner
Buy $6.5M of disclosed value in BlackRock ESG Capital Allocation Trust $ECAT.
Buy
Lind Global Fund II LP10% Owner
Sell $3.5M of disclosed value in ReWalk Robotics Ltd. $RWLK.
Sell
Helmerich HansDirector
Sell $4.3M of disclosed value in HP Inc $HP.
Sell
Lind Global Fund II LP10% Owner
Buy $3.5M of disclosed value in ReWalk Robotics Ltd. $RWLK.
Buy
Biogen Inc.10% Owner
Sell $3.0M of disclosed value in Sangamo Therapeutics, Inc. $SGMO.
Sell
Coliseum Capital Management, LLC10% Owner
Buy $6.1M of disclosed value in MasterCraft Boat Holdings, Inc. $MCFT.
Buy
Pershing Square Capital Management, L.P.10% Owner
Buy $7.3M of disclosed value in Howard Hughes Holdings Inc. $HHH.
Buy
Dinges Dan ODirector
Sell $14.7M of disclosed value in Coterra Energy Inc. Common Stock $CTRA.
Sell
Moskovitz Dustin A.Director, President, CEO, , Chair, 10% Owner
Buy $17.4M of disclosed value in Asana, Inc. $ASAN.
Buy
Rippel Douglas RichardDirector, 10% Owner
Sell $3.9M of disclosed value in FirstCash Inc $FCFS.
Sell
Kavuru VimalDirector, 10% Owner
Buy $2.5M of disclosed value in Acasti Pharma, Inc. - Class A $ACST.
Buy